Genelink IncOver The Counter Market:GNLKQ
- LAST PRICE0.0000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close--- / 0.0000
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Genelink Inc | 2.7K | 0.0x | --- |
ACI Global Corp | 320.0 | 0.0x | --- |
ER Urgent Care Holdings Inc | 40.0 | 0.0x | --- |
Arboreta Healthcare Inc | 13.7K | --- | --- |
Wellbeing Digital Sciences Inc | 130.0 | 0.0x | --- |
Diego Pellicer Worldwide Inc | 26.1K | 0.0x | --- |
Company Information
Genelink, Inc. is a supplier of custom oligonucleotides. The Company offers a range of commercially available modifications, fluorescently labeled probes, and specialized probes, such as Molecular Beacons, TaqMan, and Fluorescence resonance energy transfer (FRET), as well as a variety of other molecular biology products, such as linkers, adaptors, deoxyribonucleic acid (DNA) purification and clean-up kits. The Company’s product line of gene detection systems comprises reagents and reagent systems for scientists in the detection of genetic disorders. The Company focuses on triple repeat disorders, which include fragile x, myotonic dystrophy, huntington's disease. It also specializes in the synthesis of ribonucleic acid (RNA) modified oligos, RNA fluorescent probes with quenchers, chimeric oligos containing various combinations of DNA, 2'O methyl bases and phosphorothioate linkages. It serves various industries, including research institutes, pharmaceutical companies and hospitals.
Contact Information
- Headquarters
- 1 Westchester Plaza,, Suite 126ELMSFORD, NY, United States 10523
- Phone
- 407-680-1150
- Fax
- ---
Executives
- Executive Chairman of the Board, President, Chief Executive Officer
- Bernard Kasten
- Interim Chief Financial Officer, Chief Operating Officer
- Michael Smith
- Chief Scientific Officer, Secretary, Director
- Robert Ricciardi
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.7K |
|---|---|
Revenue (TTM) | $1.6M |
Shares Outstanding | 265.0M |
Genelink Inc does not pay a dividend. | |
Beta | --- |
EPS | $-0.01 |
Book Value | $-0.01 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -139.86% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
